Allspring Global Investments Holdings, LLC Corcept Therapeutics Inc Transaction History

Allspring Global Investments Holdings, LLC

$62.2 Billion
Q1 2024

A detailed history of Allspring Global Investments Holdings, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 126,807 shares of CORT stock, worth $3.81 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

126,807

Previous 126,807 -0.0%

Holding current value

$3.81 Million

Previous $3.19 Million -0.0%

% of portfolio

0.01%

Previous 0.01%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 18, 2024	BUY	$21.1 - $27.46 $1.23 Million - $1.61 Million	58,468 Added 85.56%	126,807 $3.19 Million
Q4 2023 Jan 25, 2024	SELL	$24.82 - $32.88 $381,185 - $504,971	-15,358 Reduced 18.35%	68,339 $2.22 Million
Q3 2023 Oct 27, 2023	BUY	$21.97 - $33.8 $1.84 Million - $2.83 Million	83,697 New	83,697 $2.28 Million
Q2 2023 Jul 18, 2023	SELL	$21.44 - $25.15 $2.08 Million - $2.44 Million	-96,859 Reduced 83.93%	18,549 $412,000
Q1 2023 Apr 13, 2023	SELL	$19.2 - $24.47 $482,304 - $614,686	-25,120 Reduced 17.88%	115,408 $2.5 Million

Q4 2022 Jan 23, 2023	BUY	$19.95 - $29.96 $1.35 Million - $2.02 Million	67,462 Added 92.33%	140,528 $0
Q3 2022 Oct 26, 2022	BUY	$24.7 - $29.12 $1.43 Million - $1.68 Million	57,775 Added 377.84%	73,066 $1.87 Million
Q2 2022 Jul 25, 2022	SELL	$17.33 - $25.3 $1.25 Million - $1.82 Million	-71,969 Reduced 82.48%	15,291 $363,000
Q1 2022 May 02, 2022	SELL	$16.53 - $25.21 $46,531 - $70,966	-2,815 Reduced 3.13%	87,260 $1.97 Million
Q4 2021 Jan 28, 2022	BUY	$17.1 - $23.34 $1.54 Million - $2.1 Million	90,075 New	90,075 $1.78 Million

Others Institutions Holding CORT

# of Institutions

316

Shares Held

93.8M

Call Options Held

2.02M

Put Options Held

3.24M

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $3.22B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account

Allspring Global Investments Holdings, LLC Corcept Therapeutics Inc Transaction History